Certara (NASDAQ:CERT) Stock, Quote.Headers.trade-ideas

Certara

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

CERT

LOVE

SDGR


While the impact of unanticipated tariff policy changes in early April was market-wide, the recovery has been less even. Despite a major rebound following the sell-off, some firms have been sluggish to reclaim lost

3 Momentum Stocks That Could Soar Post-Market Volatility

Las,Vegas,,Usa,-,April,13,,2014:,Hertz,Car,Rental

Equities

Mid Cap

News

Movers

BULL

MTSR

SBSW

VIST

ZLAB

Top mid-cap performers last week: Webull Corp, Hertz Global, Metsera Inc, Vista Energy, Certara Inc, Sibanye-Stillwater, Banco Macro, Grupo Financiero Galicia, Banco BBVA Argentina, Recursion Pharmaceuticals, Pampa Energia

Hertz Global And Webull Stocks Are Among Top Mid-Cap Gainers Last Week (Apr 14-Apr 18): Are The Others In Your Portfolio?

Woman,Hand,Holding,Plus,Icon,For,The,Healthcare,Medical,Icon.

Short Ideas

Pre-Market Outlook

Markets

SMMT

THRD

Top 3 Health Care Stocks You May Want To Dump This Quarter

Certara Inc

CertiK

CERTIVE SOLUTIONS INC by Certive Solutions, Inc.

Certive Solutions Inc

Press Releases

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

Earnings

Certara Reports Fourth Quarter 2024 Financial Results

Management

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

General

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization

Health Care

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Certara to Participate in Upcoming Investor Conferences

Certara Reports First Quarter 2025 Financial Results

Firefly Neuroscience, Inc. - Common Stock

Firefly Neuroscience

American Well Corporation Class A Common Stock

American Well

Bullfrog AI Holdings, Inc. - Common Stock

Bullfrog AI Hldgs

CareCloud

Claritev Corporation Class A Common Stock

Claritev

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare

Doximity

DarioHealth

Evolent Health

Forian

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings

Health Catalyst

HealthStream

icad

LifeMD

OptimizeRx

Phreesia

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings

Schrodinger

Simulations Plus

Sophia Genetics

TruBridge

Teladoc Health

Veeva Systems

Waystar Holding

Barclays

Keybanc

Baird

Stephens & Co.

Certicom Corp

Comments

Certara

Certara (NASDAQ:CERT) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell